Back to top

Envision Healthcare (EVHC) Q2 Earnings: What's in Store?

Read MoreHide Full Article

Envision Healthcare Corp. , expected to report  second-quarter 2018 results on Aug 6, should see an increase in revenues from its Physician Services segment (which contributes nearly 84% of the company’s revenues), driven by growth from acquisitions, organic sources, same contract revenues and net new contracts.

The company continues to make progress in negotiating its out-of-network revenues to in-network. In 2017, it migrated nearly $500 million of out-of-network revenues to in-network status. For 2018, the company targeted the migration of another $250 million of out-of-network revenues and achieved approximately $100 million of that goal till the first quarter. By yearend, it expects less than 5% of total revenuestobe out-of-network. The second quarter must have seen continued migration of out-of-network revenue to the in-network status.

Operation improvement initiatives, which included revenue cycle management, clinical labor management, and operational efficiencies from support costs that were started by the company in the fourth quarter of 2017, and primarily focused on its Physician Services segment, contributed to EBIDTA growth in the first quarter.We expect the traction to continue in the second quarter.

The company’s efforts on cost improvements are also paying off. In the first quarter, cost items were 10.9% of revenues, which is 20 basis points ahead of its expectations. The company realized $8 million of improvement across all aspects of its support structure with focused attention to personnel costs, consulting costs, and general overhead costs and the same should have occurred in the second quarter.

As a result of the recently completed American Medical Response divestiture, the company’s balance sheet should have seen an increase in cash balance. Since the company is deploying this cash for payment of debt, it must have brought down the leverage levels.

Guidance for Q2

The company expects adjusted EBITDA in a range of $234 million to $246 million. Adjusted EPS for the second quarter is expected between83 cents and 90 cents.

Earnings Surprise History

The company has an attractive earnings surprise history, having surpassed estimates in three of the trailing four quarters, with an average negative surprise of 3.89%. This is depicted in the chart below:

Envision Healthcare Corporation Price and EPS Surprise

Envision Healthcare Corporation Price and EPS Surprise | Envision Healthcare Corporation Quote

Here is what our quantitative model predicts:

Our proven model does not conclusively show that Envision Healthcare is likely to beat on earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. But that is not the case here as you will see below.

Earnings ESP: Envision Healthcare has an Earning ESP of -0.26%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

Zacks Rank: Envision Healthcare carries a Zacks Rank #3, which increases the predictive power of ESP. However, a negative ESP makes our surprise prediction difficult.

Stocks to Consider

Here are some other companies in the Medical sector that you may consider as our model shows that these too have the right combination of elements to post an earnings beat this quarter:  

Tenet Healthcare Corp. (THC - Free Report) is expected to report earnings results for the second quarter on Aug 6. The company has an Earnings ESP of +7.91% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

BioDelivery Sciences (BDSI - Free Report) has an Earnings ESP of +3.23% and a Zacks Rank of 2. The company is expected to release second-quarter results on Aug 9.

Radius Health, Inc. (RDUS - Free Report) is expected to report second-quarter fiscal 2018 earnings results on Aug7. The company has an Earnings ESP of +0.57% and a Zacks Rank #3.

Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


BioDelivery Sciences International, Inc. (BDSI) - free report >>

Radius Health, Inc. (RDUS) - free report >>

Tenet Healthcare Corporation (THC) - free report >>

More from Zacks Analyst Blog

You May Like